page_banner

Products

ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridinum-2-yl-beta-alaninatum CAS: 211915-84 -3

Description:

Catalogue Number: XD93357
Cas: 211915-84-3
Formulae hypotheticae: C27H26N6O3
Pondus hypotheticum: 482.53
Availability: In Stock
Pretium:  
Prepack:  
Mole Pack: Request Quote

 


Product Detail

Product Tags

Catalogue Number XD93357
Product Name ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninatum
CAS 211915-84-3
Formulae hypotheticaela C27H26N6O3
M. Pondus 482.53
Repono Details Ambiens

 

Product Specification

Aspectus Pulvis albus
Assay 99% min

 

Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninatum compositum chemicum complexum est. cum longo et intricato nomine.Ad genus derivationum beta-alaninatis pertinet et plures potentias usus habet. Una e applicationibus eminentium Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5 -yl)carbonyl]-N-pyridin-2-yl-beta-alaninatum in chemia medicinali est.Hoc compositum agit ut medium candidatum vel pharmaceuticum pharmacum potentiale ob singularem structuram et coetus functionis suae.Posset habere varias actiones biologicas et proprietates therapeuticas quae aptam faciunt ad ulteriorem progressionem in medicamenta.Investigatores suam potentiam explorare possunt sicut agens antimicrobiale, antimicrobiale vel anti-inflammatorium per multam biologicam inquisitionem et probationem. Adde, Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H -benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate in campo synthesis organicae adhiberi potest.Eius multiplex structura numerosas facultates praebet pro variis chemicis transformationibus et reactionibus.Chymici organici suis functionibus uti possunt ad moleculas organicas magis implicatas fabricandas vel ad specificas chemicae medietates introducendas.Composita haec compositio ad scandalum vitale aedificationis inservire potest pro synthesi aliarum compositionum cum proprietatibus formatis applicationum in scientiarum materiarum vel aliis locis specialibus inquisitionis. Compositus accuratior structura chemica benzimidazolis anuli consistit, qui bioactivity demonstravit et in saepe invenitur. componit pharmaceutical.Haec proprietas fores aperit ad ulteriorem explorationem medicamentorum potentiarum suarum quasi proprietatum.Interest notandum quod exactus usus et efficacia compositi in investigationibus comprehensivis, in pharmacokineticis studiis, biologicis inceptis, et toxicity analysis. Cum tractandis Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl} -1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninatum, cruciale est ut stricte custodias exerceat.Hoc includit opportunum apparatum tutelae gerens, in area bene ventilata operans, et inhaerens rationibus propriis tractandis ac reponendis, ne quaelibet potentia valetudinis pericula. In summa, Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl }-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninatum potentialem offert applicationes biomedicas ut medicamentum candidatum vel pharmaceuticum intermedium.Promittit etiam in synthesi organica creationem complexuum moleculorum cum proprietatibus formandis.Attamen adhuc necessariae sunt investigationes et experimenta ad plene cognoscendam et iungendam suam potentiam in his locis.


  • Priora:
  • Deinde:

  • Close

    ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridinum-2-yl-beta-alaninatum CAS: 211915-84 -3